Immunotherapy improves clinical outcome in KRAS mutated patients with unresectable NSCLC stage III: A subcohort analysis of the Austrian radio-oncological lung cancer study association regristry (ALLSTAR)
- F Zehentmayr (Author)
- M Klebermass (Author)
- B Zellinger (Author)
- B Langer (Author)
- B Grambozov (Author)
- A Purevdorj (Author)
- J Karner (Author)
- G Gruber (Author)
- M Stana (Author)
- D Minasch (Author)
- K Kirchhammer (Author)
- C Steffal (Author)
- Stranzl-Lawatsch, H. (Author)
- R Moosbrugger (Author)
- P Feurstein (Author)
- K Dieckmann (Author)
- E Ruznic (Author)
Activity: Talk, presentation or poster › Poster